通过血脑屏障 (BBB) 载体改善ChE抑制剂的血脑屏障透性的策略
Ziming Gao1, Yanyu Hu1, Na Zheng1
1School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
European journal of medicinal chemistry
|February 18, 2026
概括
研究人员开发了新型的塔克林衍生物来克服血脑屏障 (BBB),用于中枢神经系统 (CNS) 药物输送. 这些化合物利用内源运输体,显示出增强的BBB透率和新中枢神经系统治疗药物的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 血脑屏障 (BBB) 构成了中枢神经系统 (CNS) 药物输送的重大障碍.
- 制定促进跨BBB的药物运输战略对于有效的中枢神经系统治疗至关重要.
研究的目的:
- 设计和合成针对内源性BBB载体的新型塔克林衍生物,以增强中枢神经系统的药物输送.
- 评估这些衍生物在穿越BBB和抑制诸如乙胆酶 (AChE) 和丁胆酶 (BChE) 等关键酶中的有效性.
主要方法:
- 合成了两种新型系列的塔克林衍生物,其中包括四级基 (向胆载体) 和氨基酸片段 (向L型氨基酸载体1,LAT1).
- 使用bEnd.3细胞模型进行体外BBB透的评估,并测量表面透系数 (Papp).
- 在体内大脑暴露研究,并行人工膜透性试验 (PAMPA),脂友性评估,竞争性抑制试验和诱导适合的分子对接.
主要成果:
- 化合物C4在体外表现出明显更高的BBB透性,而不是塔克林.
- 化合物L3在体外表现出类似的膜透性,但在体内表现出意想不到的高脑部暴露,这表明通过LAT1.1进行活跃的运输.
- 竞争性抑制试验和分子对接证实,L3和C4分别通过LAT1和胆载体 (CHT) 运输,同时保持强大的ACHE/BChE抑制活性.
结论:
- 新型塔克林衍生物 (L3和C4) 通过利用内源输送系统 (LAT1和CHT) 有效地穿越BBB.
- 这一策略为中枢神经系统药物开发提供了有希望的化合物,可以改善大脑透.
- 这项研究有助于我们更好地理解使用内源转运体来针对性地向大脑输送治疗药物.
相关概念视频
The Blood-brain Barrier
53.7K
Overview
53.7K
Bioavailability Enhancement: Drug Permeability Enhancement
220
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
220
Physiological Barriers
5.4K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.4K
Factors Affecting Drug Distribution: Physiological Barriers
796
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
796
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
229
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
229
Hepatic Drug Clearance: Role of Transporters
332
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
332


